4/A: Citius Oncology Chief Medical Officer Amends Filing to Correct Stock Option Holdings
SEC Form 4/A (Amendment)
Myron Czuczman, Chief Medical Officer of Citius Oncology, files an amended Form 4 to correct the reported amount of stock options held following a merger transaction.
Summary
- Myron Czuczman, the Chief Medical Officer of Citius Oncology, Inc., filed an amended Form 4 with the SEC on August 30, 2024.
- The amendment corrects the amount of option shares held by Czuczman.
- The original transaction date was August 12, 2024, and the original filing date was August 14, 2024.
- Czuczman holds options to buy 1,400,000 shares of Citius Oncology common stock at an exercise price of $2.15.
- These options were originally issued by Citius Oncology Sub, Inc. and assumed by Citius Oncology, Inc. in a merger transaction that closed on August 12, 2024.
- The options vest over three years, beginning July 5, 2023, with a portion vesting monthly for the first year and the remainder vesting on the second and third anniversaries.
Sentiment
Score: 7
Explanation: The document is a routine regulatory filing. The correction of the number of shares is a neutral event.
Industry Context
Form 4 filings are standard practice for company insiders to report changes in their beneficial ownership of company securities, ensuring transparency and compliance with SEC regulations.
Stakeholder Impact
- The corrected filing provides accurate information to shareholders regarding the holdings of a key executive.
Key Dates
| Date | Description |
|---|---|
| 07/05/2023 | Start date for vesting of stock options. |
| 08/12/2024 | Date of merger transaction where Citius Oncology, Inc. assumed the stock options. |
| 08/12/2024 | Date of earliest transaction. |
| 08/14/2024 | Date of original filing. |
| 08/30/2024 | Date of amended filing. |
| 07/05/2033 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.